摘要:美国FDA于2008年12月15日批准Genzyme公司的罕见病治疗药Mozobil(通用名为Plefixafor)上市,该药可与粒细胞集落刺激因子联用以促进骨髓造血干细胞向外周血液汇集,被采集的干细胞可用于非霍奇金淋巴瘤或多发性骨髓瘤患者的自体干细胞移植。体内和体外试验均证实了Plefixafor的安全性和有效性。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering